Delivery Order SPE2DB22D3016-SPE2DB25FBHB6
- Not listed
- The Defense Logistics Agency awarded a $2,420.48 delivery order to AmerisourceBergen Drug Corp on August 25, 2025, for the supply of Proctofoam-HC 1%-1% Foam in a 10-gram formulation. This firm fixed-price contract is classified as a non-set-aside procurement and is scheduled for completion by August 26, 2025. The product will be delivered to the company's facility in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's substantial Indefinite Delivery Contract with...
- The Defense Logistics Agency awarded a delivery order valued at $4,493.20 to AmerisourceBergen Drug Corp for Proctofoam-HC 1%-1% Foam in 10-gram quantities. This order, issued on August 13, 2025, with completion targeted for August 14, 2025, represents a firm fixed-price delivery under a non-set-aside competitive procurement. The product will be performed at AmerisourceBergen's location in Conshohocken, Pennsylvania, the company's corporate headquarters. This delivery order is issued under...
- The Defense Logistics Agency awarded a $2,327.45 firm fixed-price delivery order to AmerisourceBergen Drug Corp on August 12, 2025, for Proctofoam-HC 1%-1% Foam in 10-gram units. The contract, which is non-set-aside and competitively awarded, carries an ultimate completion date of August 13, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is a child contract issued under AmerisourceBergen's larger Indefinite Delivery...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $1,724.56 on September 3, 2025, for Proctofoam-HC 1%-1% Foam in a 10-gram unit. This is a firm fixed-price, competitively awarded contract with no set-aside designation and an ultimate completion date of September 4, 2025. The contract is being performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite...
- The Defense Logistics Agency awarded a delivery order valued at $1,048.10 to AmerisourceBergen Drug Corp for Proctofoam-HC 1%-1% foam in a 10-gram unit. This award, issued on August 20, 2025, represents a firm fixed-price delivery order with an ultimate completion date of August 21, 2025, and was competitively awarded without a set-aside designation. The product will be delivered to the vendor's location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen Drug...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 28, 2025, for the supply of Proctofoam-HC 1%-1% Foam in 10-gram units, with a ceiling value of $2,029.18. This is a firm fixed price, non-set-aside contract with a completion date of August 29, 2025, to be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The delivery order represents a routine pharmaceutical procurement supporting the Defense Logistics...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 15, 2025, for Proctofoam-HC 1%-1% foam in a 10-gram unit, with a ceiling value of $1,048.10. This competitively awarded contract uses firm fixed pricing and is classified as a non-set-aside procurement. The delivery order is expected to be completed by August 18, 2025, with performance to be executed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order...
- The Defense Logistics Agency awarded a delivery order valued at $2,681.58 to AmerisourceBergen Drug Corp for Proctofoam-HC 1%-1% Foam, a topical pharmaceutical product in a 10-gram formulation. This non-competitive delivery order, issued on August 13, 2025, with an ultimate completion date of August 14, 2025, represents a firm fixed price contract. The place of performance is located in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters. As a child...
- The Defense Logistics Agency awarded a $5,030.40 firm fixed price delivery order to AmerisourceBergen Drug Corp for Proctofoam-HC 1%-1% Foam in 10-gram quantities, with an ultimate completion date of August 14, 2025. This non-set-aside competitive award represents a child order under AmerisourceBergen's larger pharmaceutical supply contract vehicle with DLA. The place of performance is AmerisourceBergen's facility in Conshohocken, Pennsylvania, where the company serves as a critical...
- The Defense Logistics Agency awarded a $2,496.84 delivery order to AmerisourceBergen Drug Corp for Proctofoam-HC 1%-1% Foam in 10-gram units, with an ultimate completion date of August 1, 2025. This firm fixed-price contract represents a non-set-aside competitive award for pharmaceutical supply delivery. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, serves as a critical vendor in the federal medical procurement supply chain, supplying a comprehensive range of pharmaceutical...
- SPE2DB22D3016Indefinite Delivery Contract
- SPE2DB22D3016-SPE2DB25FBHB6Delivery Order
The Defense Logistics Agency awarded a $1,257.60 delivery order to AmerisourceBergen Drug Corp on September 3, 2025, for the supply of Proctofoam-HC 1%-1% Foam in 10-gram quantities. This is a firm fixed price, non-set-aside contract with a completion date of September 4, 2025, and will be performed at the contractor's facility in Conshohocken, Pennsylvania. As a child delivery order under a larger contract vehicle, this award leverages AmerisourceBergen Drug Corp's existing relationship with DLA to fulfill federal medical supply requirements. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, holds a significant Indefinite Delivery Contract with DLA Troop Support Medical valued at $999,999,999.00 through December 2026. This prime contract vehicle enables the company to supply a comprehensive range of pharmaceutical products and medical supplies to support military healthcare systems globally, including specialty medications, brand-name and generic drugs, and medical devices. The company's extensive federal contracting history demonstrates its capability to meet competitive procurement requirements across multiple therapeutic domains for defense and veteran healthcare systems.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.3k | 9/3/25 |